Based on aggregate information from My MarketBeat watchlists, some companies that other Aerpio Pharmaceuticals investors own include SCYNEXIS (SCYX), VBI Vaccines (VBIV), Anavex Life Sciences (AVXL), Dynavax Technologies (DVAX), iBio (IBIO), Innovative Industrial Properties (IIPR), Novavax (NVAX), Outlook Therapeutics (OTLK), Amyris (AMRS) and Aphria (APHA). Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. See what's happening in the market right now with MarketBeat's real-time news feed. Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Do Not Sell My Information. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Do Not Sell My Information. Get the latest information on Aerpio Pharmaceuticals (ARPO) stock, including a real-time stock price quote, news, financials, charts and more. Company insiders that own Aerpio Pharmaceuticals stock include Bioventures Ltd Novartis, Joseph H Gardner, Muneer A Satter and Orbimed Advisors Llc. Aerpio Pharmaceuticals share dividends. The company reported ($0.12) EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. View which stocks are hot on social media with MarketBeat's trending stocks report. Principal Financial Officer, Principal Accounting Officer & VP of Fin. Aerpio Pharmaceuticals has received 57.14% “underperform” votes from our community. Aerpio Pharmaceuticals' mailing address is 9987 CARVER ROAD, CINCINNATI OH, 45242. The average 12-month stock price forecast for ARPO is 3.00, which is an increase of 33.33% from the latest price. Get daily stock ideas top-performing Wall Street analysts. Aerpio Pharmaceuticals, Inc., which has a market valuation of $92.06 Million as of writing, is expected to release its quarterly earnings report on Nov 10, 2020. Historical daily share price chart and data for Aerpio Pharmaceuticals since 2020 adjusted for splits. Given that is a rather small percentage, it would probably be really easy for the company to fund another year's growth by issuing some new shares to investors, or even by taking out a loan. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. All rights reserved. Stock analysis for Aerpio Pharmaceuticals Inc (ARPO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Learn more. ), Aerpio Pharmaceuticals has received 56 “underperform” votes. This will be my top watch today. © American Consumer News, LLC dba MarketBeat® 2010-2020. Principal Financial Officer, Principal Accounting Officer & VP of Fin. Since then, ARPO stock has increased by 216.7% and is now trading at $1.71. Want to see which stocks are moving? Aerpio Pharmaceuticals' stock is owned by a number of retail and institutional investors. Fundamental company data provided by Morningstar and Zacks Investment Research. A high percentage of insider ownership can be a sign of company health. Learn more. Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing compounds for the treatment of ocular diseases and diabetic complications. View all competitors. The Company' product candidates include AKB'9778, ARP1536 and AKB-4924 which are in clinical stage. There are few to no technical positive signals at the moment. ARPO Stock Forecast. Sign-up to receive the latest news and ratings for ARPO and its competitors with MarketBeat's FREE daily newsletter. Aerpio Pharmaceuticals' stock was trading at $0.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Warren Buffett recently dumped $800 million of Apple stock…And bought this instead! $3.00 (33.33% upside) You may vote once every thirty days. ARPO forecast, Aerpio Pharmaceuticals, Inc. technical analysis, Use The long-term earning potential is Aerpio Pharmaceuticals, Inc. quote is equal to … (Add your “outperform” vote. Get the latest Aerpio Pharmaceuticals, Inc. ARPO detailed stock quotes, stock … View which stocks have been most impacted by COVID-19. Post-Market 0.92 (40.89%) View our full suite of financial calendars and market data tables, all for free. You may vote once every thirty days. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. There are 32 institutions holding the Aerpio Pharmaceuticals, Inc. stock share, with Orbimed Advisors LLC. Aerpio Pharmaceuticals earnings estimates module stress-tests analyst consensus about projected Aerpio Pharmaceuticals EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Aerpio Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "ARPO.". Sign-up to receive the latest news and ratings for ARPO and its competitors with MarketBeat's FREE daily newsletter. Should I buy or sell ARPO? Aerpio Pharmaceuticals does not have a long track record of dividend growth. Aerpio Pharmaceuticals, Inc. has a collaboration with Quantum Leap Healthcare Collaborative for the evaluation of razuprotafib in the treatment of acute respiratory distress syndrome in adult patients with moderate to severe COVID-19. Price target in 14 days: 2.575 USD. Momentum investing revolves around the idea of following a stock's recent trend in either direction. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. (Add your “underperform” vote.). Wall Street Stock Market & Finance report, prediction for the future: You'll find the Aerpio Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Aerpio Pharmaceuticals… * Our share forecasts and predictions are made by, Aerpio Pharmaceuticals, Inc. Forecast. View which stocks have been most impacted by COVID-19. Find out now with a free analysis on Aerpio Pharmaceuticals. Aerpio Pharmaceuticals does not currently pay a dividend. Aerpio Pharmaceuticals' management team includes the following people: Founder, Pres, Principal Exec. Some companies that are related to Aerpio Pharmaceuticals include Matinas BioPharma (MTNB), Matinas BioPharma (MTNB), IMV (IMV), iBio (IBIO), 4D pharma plc (DDDD.L) (DDDD), Bioventix PLC (BVXP.L) (BVXP), Faron Pharmaceuticals Oy (FARN.L) (FARN), Resverlogix Corp. (RVX.TO) (RVX), BELLUS Health (BLU), Medicenna Therapeutics (MDNA), Rezolute (RZLT), Actinium Pharmaceuticals (ATNM), Actinium Pharmaceuticals (ATNM), Horizon Discovery Group plc (HZD.L) (HZD) and Arix Bioscience plc (ARIX.L) (ARIX). To see all exchange delays and terms of use please see disclaimer. Aerpio Pharmaceuticals does not have a long track record of dividend growth. Since then, ARPO shares have increased by 122.2% and is now trading at $1.20. ARPO stock was acquired by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Boothbay Fund Management LLC, Virtu Financial LLC, Arrowstreet Capital Limited Partnership, Lindbrook Capital LLC, and Jane Street Group LLC. Aerpio Pharmaceuticals Inc. is a biopharmaceutical company. Vote “Underperform” if you believe ARPO will underperform the S&P 500 over the long term. New 5G "Arrow" to Replace Nuclear Missiles. On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. Aerpio Pharmaceuticals Inc (ARPO) Analyst Forecast Next 12 months MEAN $2.00 +49.25% Current Price $1.34 52-week High $1.90 52-week Low $0.42 Last Price $1.34 2 Wall Street analysts have issued 12-month price objectives for Aerpio Pharmaceuticals' shares. On corrections up, there will be some resistance from the lines at $1.89 and $1.58.A break-up above any of these levels will issue buy signals. Aerpio Pharmaceuticals' stock was trading at $0.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. FedEx (NYSE: FDX) is a Buy Ahead of Earnings, MarketBeat: Week in Review 12/7 – 12/11, Switch Back Energy (NYSE: SBE) a Legit EV Charging Play, Hooker Furniture (NASDAQ:HOFT) Is A Comfortable Small-Cap Dividend, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. The company's lead product candidate is razuprotafib, a small molecule activator of the Tie2 pathway, which completed the Phase IIb clinical trial for the treatment of diabetic retinopathy. In the past three months, Aerpio Pharmaceuticals insiders have sold more of their company's stock than they have bought. The company can be reached via phone at 513-985-1920. ARPO | Complete Aerpio Pharmaceuticals Inc. stock news by MarketWatch. Top institutional shareholders include Acadian Asset Management LLC (2.81%), Boothbay Fund Management LLC (0.88%), Arrowstreet Capital Limited Partnership (0.08%), Lindbrook Capital LLC (0.07%) and Jane Street Group LLC (0.04%). Based on aggregate information from My MarketBeat watchlists, some companies that other Aerpio Pharmaceuticals investors own include Bausch Health Companies (BHC), Trevena (TRVN), CorMedix (CRMD), VBI Vaccines (VBIV), Ampio Pharmaceuticals (AMPE), MannKind (MNKD), Sorrento Therapeutics (SRNE), Aldeyra Therapeutics (ALDX), Biocept (BIOC) and BioLineRx (BLRX). As of 2020 November 14, Saturday current price of ARPO stock is 1.350$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Aerpio Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. According to analysts' consensus price target of $2.75, Aerpio Pharmaceuticals has a forecasted upside of 129.2% from its current price of $1.20. Shares of ARPO can be purchased through any online brokerage account. Want to see which stocks are moving? Aerpio Pharmaceuticals has a market capitalization of $56.53 million. Latest Share Price and Events Stable Share Price : ARPO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week. Identify stocks that meet your criteria using seven unique stock screeners. The company is headquartered in Cincinnati, Ohio. The expected earnings per share for the stock is $0. The Aerpio Pharmaceuticals Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. The share float percentage for the stock currently stands at 49.46%. 1.350 USD to Best Aerpio Pharmaceuticals, Inc. forecast, Aerpio Pharmaceuticals, Inc. quote is equal to 1.350 USD at 2020-11-11. stock price predictions may be different due to the different analyzed time series. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Officer & Director. Uncategorized aerpio pharmaceuticals stock forecast By 1 second ago . Aerpio Pharmaceuticals has received 99 “outperform” votes. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Chief Scientific Officer & Acting Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, The Furniture Industry Is Levered For Big Profits, Shift Technologies (NASDAQ: SFT) Stock is an Under the Radar Car Platform, Hexo Corporation (NASDAQ:HEXO) Is On Track For Profitability. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Vote “Outperform” if you believe ARPO will outperform the S&P 500 over the long term. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Officer & Director. Learn more. Aerpio Pharmaceuticals share price volatility. Aerpio Pharmaceuticals ARPO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. FedEx (NYSE: FDX) is a Buy Ahead of Earnings, Switch Back Energy (NYSE: SBE) a Legit EV Charging Play, Hooker Furniture (NASDAQ:HOFT) Is A Comfortable Small-Cap Dividend, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, Horizon Discovery Group plc (HZD.L) (HZD), Receive Analysts' Upgrades and Downgrades Daily. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The official website for Aerpio Pharmaceuticals is www.aerpio.com. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; GB004, a selective stabilizer of hypoxia-inducible factor-1 alpha, which is in a Phase 1b clinical trial for the treatment of inflammatory bowel disease; and bispecific antibody for the treatment for wet age-related macular degeneration and DME through intravitreal injection. Starbucks (NASDAQ: SBUX) Eyes Expansion, Do Shares Have More Room to Run? Learn more. Steve has served on Aerpio’s board of directors since March 2017. Aerpio Pharmaceuticals, Inc. has a collaboration with Quantum Leap Healthcare Collaborative for the evaluation of razuprotafib in the treatment of acute respiratory distress syndrome in adult patients with moderate to severe COVID-19. Looking for new stock ideas? Some companies that are related to Aerpio Pharmaceuticals include OptiNose (OPTN), Milestone Pharmaceuticals (MIST), vTv Therapeutics (VTVT), Sesen Bio (SESN), ProQR Therapeutics (PRQR), Matinas BioPharma (MTNB), IMV (IMV), Aptinyx (APTX), iBio (IBIO), Eton Pharmaceuticals (ETON), Oasmia Pharmaceutical AB (publ) (OASMY), Assembly Biosciences (ASMB), Cerecor (CERC), Cassava Sciences (SAVA) and Neptune Wellness Solutions (NEPT). Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The latest closing stock price for Aerpio Pharmaceuticals as of December 10, 2020 is 2.22.. View analyst ratings for Aerpio Pharmaceuticals or view MarketBeat's top 5 stock picks. Find the latest Aerpio Pharmaceuticals, Inc. (ARPO) stock quote, history, news and other vital information to help you with your stock trading and investing. Receive a free world-class investing education from MarketBeat. Company insiders that have bought Aerpio Pharmaceuticals stock in the last two years include Joseph H Gardner, and Muneer A Satter. It focuses on the development of novel therapeutics for vascular disorders with a concentration on diseases of the eye. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing compounds for the treatment of ocular diseases and diabetic complications. 38.60% of the stock of Aerpio Pharmaceuticals is held by insiders. Learn everything you need to know about successful options trading with this three-part video course. One share of ARPO stock can currently be purchased for approximately $1.20. How has Aerpio Pharmaceuticals's share price performed over time and what events caused price changes? Aerpio Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ARPO.". Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. MarketBeat just released five new trading ideas, but Aerpio Pharmaceuticals wasn't one of them. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for info The all-time high Aerpio Pharmaceuticals stock closing price was 4.27 on July 09, 2018.; The Aerpio Pharmaceuticals 52-week high stock price is 2.31, which is 4.1% above the current share price. Aerpio Pharmaceuticals Stock Price Forecast, ARPO stock price prediction. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Aerpio Pharmaceuticals employs 12 workers across the globe. Since then, ARPO stock has increased by 122.2% and is now trading at $1.20. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Top institutional investors include Acadian Asset Management LLC (2.81%), Boothbay Fund Management LLC (0.88%), Virtu Financial LLC (0.08%), Arrowstreet Capital Limited Partnership (0.08%), Lindbrook Capital LLC (0.07%) and Jane Street Group LLC (0.04%). Aerpio Pharmaceuticals has only been the subject of 2 research reports in the past 90 days. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Despite being -3.31% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Sep 30 when the ARPO stock price touched $1.72 or saw a rise of 15.12%. Starbucks (NASDAQ: SBUX) Eyes Expansion, Do Shares Have More Room to Run? This has the potential to have a large run. Aerpio Pharmaceuticals, Inc. Stock Price Forecast, "ARPO" Predictons for2020 One share of ARPO stock can currently be purchased for approximately $1.20. Looks like a gap from 1.50s to the 3.50-4 area. Aerpio Pharmaceuticals' stock is owned by many different retail and institutional investors. Only 0.37% of the stock of Aerpio Pharmaceuticals is held by institutions. Most stock quote data provided by BATS. Vote “Outperform” if you believe ARPO will outperform the S&P 500 over the long term. As of Sep 29, 2020, the company held 12.8% of the shares, roughly 5.19 Million ARPO shares worth $7.79 Million. "Start by doing what is necessary, then what is possible, and suddenly you are doing the impossible." About the Aerpio Pharmaceuticals, Inc. stock forecast. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Aerpio Pharmaceuticals does not currently pay a dividend. He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…, Founder, Pres, Principal Exec. aerpio pharmaceuticals stock forecast. ), Aerpio Pharmaceuticals has received 106 “underperform” votes. in Finance and Accounting from the University of Massachusetts, Amherst. Learn everything you need to know about successful options trading with this three-part video course. The company is headquartered in Cincinnati, Ohio. Aerpio Pharmaceuticals Inc. ARPO 2.25 0.03 (1.35%). Aerpio Pharmaceuticals employs 12 workers across the globe. ARPO Stock Forecast - Is ARPO a buy or sell? Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Aerpio Pharmaceuticals' stock was trading at $0.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Export data to Excel for your own analysis. There is not enough analysis data for Aerpio Pharmaceuticals. Looking for new stock ideas? Never miss … WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Price Target. Learn about financial terms, types of investments, trading strategies and more. Mr. Prelack has been the Chief Operating Officer and Senior Vice President of VetCor since 2010. Find the latest Earnings Report Date for Aerpio Pharmaceuticals, Inc. Common Stock (ARPO) at Nasdaq.com. Aerpio Pharmaceuticals is one of 892 individual stocks in the Medical sector. Please log in to your account or sign up in order to add this asset to your watchlist.